BIOMAT Database Logo BIOMAT Database Logo

Potential histidine decarboxylase inhibitors. 1. alpha- and beta-substituted histidine analogues. 1977

J I DeGraw, and J Engstrom, and M Ellis, and H L Johnson

Histidine analogues with alkyl substitution at Calpha and Cbeta were prepared as potential inhibitors of specific histidine decarboxylase. Activity was assessed in vitro using extracts of rat pyloric stomach and a radioisotopic assay of 14CO2 evolved from carboxyl-14C-labeled histidine. alpha-Substituted analogues (C2-C4) including 2-hydroxyethyl were less potent than alpha-methylhistidine; the alpha-n-butyl analogue was completely inactive at 10(-3) M. Similarly, beta,beta-dimethylhistidine and homohistidine failed to exhibit activity at 10(-3) M.

UI MeSH Term Description Entries
D002262 Carboxy-Lyases Enzymes that catalyze the addition of a carboxyl group to a compound (carboxylases) or the removal of a carboxyl group from a compound (decarboxylases). EC 4.1.1. Carboxy-Lyase,Decarboxylase,Decarboxylases,Carboxy Lyase,Carboxy Lyases
D006639 Histidine An essential amino acid that is required for the production of HISTAMINE. Histidine, L-isomer,L-Histidine,Histidine, L isomer,L-isomer Histidine
D006640 Histidine Decarboxylase An enzyme that catalyzes the decarboxylation of histidine to histamine and carbon dioxide. It requires pyridoxal phosphate in animal tissues, but not in microorganisms. EC 4.1.1.22. Histidine Carboxy-Lyase,Carboxy-Lyase, Histidine,Decarboxylase, Histidine,Histidine Carboxy Lyase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013270 Stomach An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM. Stomachs
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

J I DeGraw, and J Engstrom, and M Ellis, and H L Johnson
Attempted inhibition of histidine decarboxylase with beta-alkyl analogues of histidine.
May 1977, Journal of medicinal chemistry,
J I DeGraw, and J Engstrom, and M Ellis, and H L Johnson
A study of potential histidine decarboxylase inhibitors.
December 1960, British journal of pharmacology and chemotherapy,
J I DeGraw, and J Engstrom, and M Ellis, and H L Johnson
[Histidine decarboxylase inhibitors].
July 1973, Acta pharmaceutica Hungarica,
J I DeGraw, and J Engstrom, and M Ellis, and H L Johnson
Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
September 2007, Bioorganic & medicinal chemistry letters,
J I DeGraw, and J Engstrom, and M Ellis, and H L Johnson
Ornithine analogs as potential ornithine decarboxylase inhibitors 1. N-Substituted ornithine derivatives.
April 1972, Journal of medicinal chemistry,
J I DeGraw, and J Engstrom, and M Ellis, and H L Johnson
Imidazole derivatives. Histidine decarboxylase inhibitors.
September 1970, Journal of medicinal chemistry,
J I DeGraw, and J Engstrom, and M Ellis, and H L Johnson
Synthesis of five N-derivatives of 1,2,3,4-tetrahydroisoquinoline and three N alpha terminal histidine peptides as potential gastric histidine decarboxylase inhibitors.
February 1983, Bollettino chimico farmaceutico,
J I DeGraw, and J Engstrom, and M Ellis, and H L Johnson
alpha-(Fluoromethyl)dehydroornithine and alpha-(fluoromethyl)dehydroputrescine analogues as irreversible inhibitors of ornithine decarboxylase.
November 1983, Journal of medicinal chemistry,
J I DeGraw, and J Engstrom, and M Ellis, and H L Johnson
Substituted Benzimidazole Analogues as Potential α-Amylase Inhibitors and Radical Scavengers.
September 2021, ACS omega,
J I DeGraw, and J Engstrom, and M Ellis, and H L Johnson
Histidine decarboxylase inhibitors and second-set allograft survival.
October 1969, Archives of surgery (Chicago, Ill. : 1960),
Copied contents to your clipboard!